Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The G60S Connexin43 mutation causes hair growth issues and poor hair quality in mice, similar to human ODDD patients.

Hair, teeth, and mammary glands develop similarly at first but use different genes later.

The document provides a comprehensive index of medical and surgical topics, including hair removal, hair restoration, and various treatments for injuries and conditions.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

High lactate dehydrogenase activity is not necessary for the growth of squamous cell carcinoma.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

A specific gene variant is linked to heart disease, increased heart muscle, curly hair, and thick skin on palms and soles.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

Understanding the genetics of rare inherited ichthyosis syndromes is key for better treatments and genetic counseling.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

A new mutation in the DCAF17 gene was found in a Chinese family, causing Woodhouse-Sakati syndrome and diabetes.

Sleep problems and skin issues affect each other; poor sleep can worsen skin conditions, and some skin treatments can improve or harm sleep quality.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Hair loss and excessive growth treated with various options, including new laser technology.

Using platelet growth factors can improve hair density in transplants, especially for those with fine hair.

Genetics and hormones cause hair loss; finasteride treats it safely.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Improper diet, lifestyle, and stress are major causes of hair fall.